Sunrise Labs Job Opportunity: Impact Medical Technology as a Software Engineer & Architect

 

With healthy growth rates projected for the medical technology and devices industry globally, MedTech careers are in high demand. On this episode of Making Bright Ideas Work, we break down how two open positions in the software and product development field at Sunrise Labs are affecting medical change on an industry level. To share their insight, host Daniel Litwin sat down with Jim Turner, director of software development, and Mike Goulet, program manager & software technical lead.

“We have a lot of opportunities here at Sunrise,” Turner said. Sunrise Labs has been delivering medical device design and engineering expertise for more than 25 years.

The Embedded Software Engineer is tasked with leading the company forward into new product markets, bringing deep C or C++ skills, Linux applications experience, and wireless protocol experience. Personality-wise, Sunrise is looking for someone with a strong, driving desire to bring cutting-edge products to the table, Goulet said.

In addition, Sunrise is seeking a Software Architect who’ll be tasked with architecting, leading, and developing medical device software, including embedded software. They’ll lead a software development team, provide project direction using agile development methods, and write detailed software design descriptions.

The key to success in these positions, Turner said, is the unparalleled ability for employees to express themselves well. That’s because both these positions will have a hand in crafting important, industry-affecting devices that improve real patients’ lives.

Give this a listen to learn more about the culture at Sunrise Labs, why their energy draws parallels to Hamilton the Musical, and what you should do to prepare for the interview.

If you’d like to apply for either position, click here.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @HealthMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More